5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

NCT03366116 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

65

Enrollment

NIH

Sponsor class

Conditions

Neoplasms
Solid Tumors

Interventions

DRUG: aza-TdC

Sponsor

National Cancer Institute (NCI)